Shima Jahani

Shima Jahani

Auto-generated profile, based on publicly available information

Shima Jahani

Multiple Sclerosis Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2024 in Frontiers in Health Informatics
Verified
Journal Article
Open access
PDF file
AAAmir Masoud Afsahi
Amir Masoud Afsahi
SASeyed Ahmad Seyed Alinaghi
Seyed Ahmad Seyed Alinaghi
AMAyoob Molla
Ayoob Molla
PMPegah Mirzapour
Pegah Mirzapour
SJShima Jahani
Shima Jahani
EMEsmaeil Mehraeen
Esmaeil Mehraeen
Introduction: Chatbots, computer programs emulating natural language conversations, have gained attention in healthcare. Recent advances address issues like obesity, dementia, oncology, and insomnia. A comprehensive assessment of their utility is essential for widespread adoption. This study aims to summarize chatbots' role in healthcare.Material and Methods: The methodology involved a systematic review of English-language literature up to May 8, 2023, from databases of Embase, PubMed, Web of Science, and Scopus. Selection followed a two-step process based on inclusion/exclusion criteria. The PRISMA checklist and AMSTAR-2 tool ensured quality.Results: The review encompassed 38 articles. Findings reveal chatbots primarily promote healthy lifestyles, improving mental well-being. They are widely used for treatment, education, and screening due to their accessibility.Conclusion: Chatbots hold transformative potential in healthcare, especially in mental health, cancer management, and public health. They are poised to revolutionize the industry, offering innovative solutions and improving patient outcomes.

21 December 2024 in Regenerative Therapy
Verified
Journal Article
Open access
AFAli Faegh
Ali Faegh
SJShima Jahani
Shima Jahani
FCFatemeh Chinisaz
Fatemeh Chinisaz
HBHamoon Baghaei
Hamoon Baghaei
MZMasoumeh Majidi Zolbin
Masoumeh Majidi Zolbin
Tissue engineering has been considered a potential choice for urinary system reconstruction. Here, we aim to a broad spectrum of employed stem cells in bladder regeneration by performing a comprehensive systematic review. In January 2024, we searched Scopus, PubMed, and Embase databases for studies that tried bladder regeneration by tissue engineering using stem cells. We excluded non-English studies, review articles, and manuscripts that met the other exclusion criteria. Among 43 included studies, comparative studies demonstrated the similar or superior potentiality of stem cells to regenerate tissues and improve bladder function compared with autologous cells. Furthermore, data suggest an increased use of bio-synthetic scaffolds and their appropriate bio-compatibility with stem cells. The evidence establishes that adipose-derived and bone marrow-derived mesenchymal stem cells are the most frequently used stem cells. And both are suitable for urothelium and smooth muscle formation along with the capability of bone marrow-derived mesenchymal stem cells for lamina propria formation. Additionally, the competency of smooth muscle-derived progenitor cells, urine-derived stem cells, umbilical mesenchymal SCs for smooth muscle and urothelium regeneration, and the capability of hair follicle stem cells for smooth muscle formation are demonstrated. Also, the superiority of endothelial progenitor cells for neo-vascularization and smooth muscle progenitor cells for neuron formation are demonstrated. In addition to adding growth factors to the culturing media, hypoxic conditions and intra-peritoneal incubation are introduced as promoter conditions that can improve histological and physiological components. Available evidence is limited, although it suggests the precious capability of stem cells for bladder regeneration.

6 January 2025 in Clinical Case Reports
Verified
Journal Article
Open access
SJShima Jahani
Shima Jahani
FJFateme Jamshidi
Fateme Jamshidi
AMAbdorreza Naser Moghadasi
Abdorreza Naser Moghadasi
Here we present a rare case of hemorrhagic longitudinally extensive transverse myelitis (LETM) as a first presentation of Neuromyelitis Optica Spectrum Disorder. Even though the patient received aggressive treatment, he showed no significant improvement. Our case highlights the importance of prompt intervention in the case of hemorrhagic myelitis and the diagnostic challenges of hemorrhagic LETM.

1 January 2025 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
MLMahsa Mohammadi Lapevandani
Mahsa Mohammadi Lapevandani
EBElham Bazmi
Elham Bazmi
SJShima Jahani
Shima Jahani
NANasrin Asgari
Nasrin Asgari
MSMohammad Ali Sahraian
Mohammad Ali Sahraian
Background: Neuromyelitis optica spectrum disorder (NMOSD) may be triggered by environmental risk factors. Objectives: We aimed to explore and integrate the recent research advances in this field. Here we describe relevant studies and summarize current knowledge on non-genetic factors that influence the onset of the disease. Design: Systematic review. Methods: We performed a systematic review up to May 21, 2024, following preferred reporting items for systematic reviews and meta-analyses guidelines. Two independent reviewers evaluated the quality of the included studies using the Joanna Briggs Institute checklist for risk of bias assessment. Data sources: MEDLINE, EMBASE, Scopus, and Web of Science databases. Results: A total of 15,869 articles were evaluated. Of those 50 studies met the eligibility criteria. A total of 21,410 NMOSD patients were included in the studies; 17,080 patients were females. Totally, 14 risk factors, including vitamin D deficiency, vaccination, virus infections, lifestyle, and dietary factors, were assessed. A total of 37% of the included articles were conducted in East Asia, mainly focusing on the effects of infection and vitamin D deficiency. These studies suggested vitamin D deficiency as a possible NMOSD risk factor. A total of 25% of the studies included Caucasian populations from Western countries. They showed that smoking decreased the odds of NMOSD, in contrast to observations from Eastern studies. Few cases reported NMOSD onset after COVID-19 vaccination. Antibodies against Epstein-Barr virus, Mycobacterium paratuberculosis , and Helicobacter pylori were observed to be more frequently positive in the serum of NMOSD patients. Lower protein and fat and higher carbohydrate intakes were correlated with NMOSD development. Conclusion: Vitamin D deficiency, cigarette smoking, Mycobacterium avium subspecies paratuberculosis infection, and diet were reported as environmental risk factors for NMOSD. The difference in the onset of NMOSD between Asian and Caucasian populations could be affected by smoking and vitamin D deficiency. Knowledge of modifiable risk factors for NMOSD may be beneficial in preventing and improving disease outcomes.

7 August 2024 in Clinical Case Reports
Verified
Journal Article
Open access
SJShima Jahani
Shima Jahani
AMAbdorreza Naser Moghadasi
Abdorreza Naser Moghadasi
Key Clinical Message: Here we present a co‐occurrence of a non‐typical presentation of DIG/DIA and multiple sclerosis in a 13‐year‐old female. Our case highlights how a thorough investigation prior to treatment is needed in patients with such condition to choose proper management for better prognosis.

1 January 2025 in Clinical Neuroimaging
Verified
Journal Article
Open access
Sadegh GhaderiSadegh Ghaderi
Sadegh Ghaderi
Sana MohammadiSana Mohammadi
Sana Mohammadi
SJShima Jahani
Shima Jahani
Objective: To conduct a comprehensive meta‐analysis on glymphatic system dysfunction in relapsing‐remitting multiple sclerosis (RRMS) using the diffusion tensor imaging along the perivascular space (DTI‐ALPS) index compared with healthy controls (HCs). Methods: This review followed PRISMA guidelines and systematically searched PubMed, Web of Science, Scopus, and Embase up to July 14, 2025. Inclusion criteria focused on studies utilizing DTI‐ALPS to compare glymphatic function in RRMS patients with HCs. The standardized mean difference (SMD) was calculated using a random‐effects model. Subgroup analyses and meta‐regression were performed to investigate potential sources of heterogeneity. Results: Data were extracted from seven eligible studies, comprising a total of 405 RRMS patients (36% male) and 303 HCs. A statistically significant and robust reduction in the DTI‐ALPS index was observed in patients with RRMS (SMD = −0.58, 95% CI: −0.78 to −0.38; p < 0.001), indicating impaired glymphatic function. The analysis revealed moderate heterogeneity among studies ( I 2 = 37.17%). Meta‐regression revealed that age and disease duration fully explained the heterogeneity. No publication bias or risk of bias was detected. Conclusion: The DTI‐ALPS index revealed glymphatic dysfunction in RRMS, highlighting the importance of investigating glymphatic impairment in MS.